Lexeo Therapeutics Overview
Lexeo Therapeutics (LXEO) has a PEG ratio of 310.66, above the sector sector average of 10.05.
Get informed when a big investor buys or sells
+ Follow310.66
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, LXEO shows a PEG ratio of 310.66. That is above the sector sector average of 10.05. Scroll down for historical charts and peer comparison views.
The its sector sector average PEG ratio is about 10.05. Lexeo Therapeutics is at 310.66, which is higher that average. That is roughly 2989.6% above the sector mean. Use the comparison chart on this page to see how LXEO stacks up against individual peers as well.
Investors watch LXEO's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Lexeo Therapeutics's latest reading is 310.66. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Lexeo Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 310.66) with ownership activity and broader fundamentals.
